The shares of Moderna Inc. underperforming on Monday compared to competitors

by

Shares of Moderna Inc. MRNA,
-9.72%
slid 9.72% to $ 111.40 Monday, on what turned out to be an all-round favorable trading session for the stock market, with the NASDAQ Composite Index COMP,
+ 0.74%
an increase of 0.74% to 12,899.42 and the Dow Jones Industrial Average DJIA,
+ 0.68%
rising 0.68% to 30,403.97. This was the stock’s second consecutive day of losses. Moderna Inc. closed at $ 67.10 below its 52-week high ($ 178.50), which the company reached on December 1.

The stock underperformed compared to some of its competitors on Monday, such as AbbVie Inc. ABBV,
+ 0.18%
rose 0.18% to $ 103.45, Amgen Inc. AMGN,
+ 0.32%
increased 0.32% to $ 223.65, and AstraZeneca PLC ADR AZN,
+ 1.77%
rose 1.77% to $ 49.38. The trade volume (30.7 million) eclipsed the 50-day average volume of 23.1 million.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

.Source